ArticleArthritis research & therapy2021

Tofacitinib downregulates antiviral immune defence in keratinocytes and reduces T cell activation.

Heike C Hawerkamp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.